WO2008102037A8 - Uso de compuestos como inhibidores de la flavodoxina de helicobacter - Google Patents

Uso de compuestos como inhibidores de la flavodoxina de helicobacter Download PDF

Info

Publication number
WO2008102037A8
WO2008102037A8 PCT/ES2008/000093 ES2008000093W WO2008102037A8 WO 2008102037 A8 WO2008102037 A8 WO 2008102037A8 ES 2008000093 W ES2008000093 W ES 2008000093W WO 2008102037 A8 WO2008102037 A8 WO 2008102037A8
Authority
WO
WIPO (PCT)
Prior art keywords
helicobacter
flavodoxin
inhibitors
compounds
equals
Prior art date
Application number
PCT/ES2008/000093
Other languages
English (en)
French (fr)
Other versions
WO2008102037A1 (es
Inventor
Sanz Javier Sancho
Campoy Adrian Velazquez
Casasin Nunilo Cremades
Original Assignee
Univ Zaragoza
Sanz Javier Sancho
Campoy Adrian Velazquez
Casasin Nunilo Cremades
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Zaragoza, Sanz Javier Sancho, Campoy Adrian Velazquez, Casasin Nunilo Cremades filed Critical Univ Zaragoza
Priority to US12/528,278 priority Critical patent/US8080664B2/en
Priority to EP08736697A priority patent/EP2113251A4/en
Priority to JP2009550299A priority patent/JP5324475B2/ja
Publication of WO2008102037A1 publication Critical patent/WO2008102037A1/es
Publication of WO2008102037A8 publication Critical patent/WO2008102037A8/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Uso del compuesto de fórmula general (I), o cualquiera de sus sales, para Ia elaboración de una composición farmacéutica para el tratamiento de enfermedades infecciosas, más particularmente para el tratamiento de helicobacter. Y es NO2, COOH ó SO3H; Z es O, N ó S; X1 y X2 son halógenos y pueden ser iguales o diferentes; y m y n toma valores de entre O a 3 y pueden ser iguales o diferentes.
PCT/ES2008/000093 2007-02-23 2008-02-20 Uso de compuestos como inhibidores de la flavodoxina de helicobacter WO2008102037A1 (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US12/528,278 US8080664B2 (en) 2007-02-23 2008-02-20 Use of compounds as inhibitors for Helicobacter flavodoxin
EP08736697A EP2113251A4 (en) 2007-02-23 2008-02-20 USE OF COMPOUNDS AS INHIBITORS OF HELICOBACTER FLAVODOXIN
JP2009550299A JP5324475B2 (ja) 2007-02-23 2008-02-20 ヘリコバクターフラボドキシン阻害剤としての化合物の利用

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200700566A ES2304112B1 (es) 2007-02-23 2007-02-23 Uso de compuestos como inhibidores de la flavodoxina de helicobacter.
ESP200700566 2007-02-23

Publications (2)

Publication Number Publication Date
WO2008102037A1 WO2008102037A1 (es) 2008-08-28
WO2008102037A8 true WO2008102037A8 (es) 2009-07-23

Family

ID=39708046

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/ES2008/000093 WO2008102037A1 (es) 2007-02-23 2008-02-20 Uso de compuestos como inhibidores de la flavodoxina de helicobacter

Country Status (5)

Country Link
US (1) US8080664B2 (es)
EP (1) EP2113251A4 (es)
JP (1) JP5324475B2 (es)
ES (1) ES2304112B1 (es)
WO (1) WO2008102037A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2853530A1 (en) * 2013-09-25 2015-04-01 Université de Rennes 1 New PI3K/AKT/mTOR inhibitors and pharmaceutical uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3394191A (en) * 1966-02-09 1968-07-23 Monsanto Co Phenyl beta-nitrostyryl sulfides
US3629465A (en) * 1966-08-22 1971-12-21 Givaudan Corp Preservatives for aqueous systems
US3985761A (en) * 1974-10-24 1976-10-12 Sarabhai Research Centre Nitrothiazolyl derivatives of nitrostyrene
WO1988003147A1 (en) 1986-10-31 1988-05-05 Warner-Lambert Company Selected n6-substituted adenosines having selective a2 binding activity
US5763470A (en) * 1995-06-07 1998-06-09 Sugen Inc. Benzopyran compounds and methods for their use
GB9526407D0 (en) 1995-12-22 1996-02-21 Glaxo Group Ltd Substances and their uses
ATE260242T1 (de) 1998-12-17 2004-03-15 Hoffmann La Roche 7-aryl-6(z)heptatriensäure retinamide als apoptose induzierende verbindungen und deren verwendung als antikrebsmittel
DE10045599B4 (de) * 2000-09-15 2004-06-03 Wella Ag Haarfärbemittel auf der Basis von 4-Nitro-2,1,3-benzoxadiazol-Derivaten und dessen Verwendung als Farbstoff zum Färben von Haaren
US20040167189A1 (en) * 2002-03-22 2004-08-26 The Government Of The U.S.A., As Represented By The Secretary, Dept. Of Health And Human Services Materials and methods for inhibiting Wip1
US7638554B2 (en) * 2002-04-18 2009-12-29 Sri International Flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents
ITRM20030194A1 (it) * 2003-04-24 2004-10-25 Univ Roma Uso di derivati del 7-nitro-2, 1, 3-benzossadiazolo per
CA2557144A1 (en) * 2004-02-23 2005-09-09 Prolexys Pharmaceuticals Inc. Non-peptidyl agents with phsp20-like activity, and uses thereof
JP2008503591A (ja) * 2004-06-22 2008-02-07 ライジェル ファーマシューティカルズ， インコーポレイテッド ユビキチンリガーゼ阻害剤

Also Published As

Publication number Publication date
EP2113251A4 (en) 2010-07-21
EP2113251A1 (en) 2009-11-04
WO2008102037A1 (es) 2008-08-28
ES2304112B1 (es) 2009-08-13
US8080664B2 (en) 2011-12-20
JP5324475B2 (ja) 2013-10-23
ES2304112A1 (es) 2008-09-01
US20100317862A1 (en) 2010-12-16
JP2010519245A (ja) 2010-06-03

Similar Documents

Publication Publication Date Title
EP1730163A4 (en) Pharmaceutical salts of 3-O- (3,3-dimethylsuccinyl) betulinic acid
WO2009135179A3 (en) The use of solid carrier particles to improve the processability of a pharmaceutical agent
EA201001205A1 (ru) Соединения, содержащие циклобутоксигруппу
RS54123B1 (en) THERAPEUTIC COMBINATION CONTAINING DOLUTEGRAVIR, ABACAVIR AND LAMIVUDINE
WO2008013838A3 (en) Pyridizinone derivatives
WO2008142055A3 (en) Antiviral agents
WO2009016410A3 (en) Chemical compounds 831
MY151986A (en) Adamantyl diamide derivatives and uses of same
UA105229C2 (uk) Фармацевтичний склад
WO2006122319A3 (en) Histone deacetylase inhibitors
WO2007030361A3 (en) Benzimidazole thiophene compounds as plk inhibitors
WO2009083940A3 (en) Processes for the preparation of 2,5-dihydroxybenzenesulfonic acid salts
ATE460401T1 (de) 1,2,4,5-tetrahydro-3h-benzazepinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
WO2009105969A8 (zh) 埃坡霉素类似物、其药物组合物、用途及其制备方法
WO2009013545A3 (en) Chemical compounds
RS52108B (en) 3-SUBSTITUTED [1,2,3] -BENZOTRIAZINONE UNIT TO INCREASE GLUTAMATERGIC SYNAPTIC ANSWERS
EA201001855A1 (ru) Соединения, содержащие циклобутоксигруппу
NO20084543L (no) Benzimidazolderivater
IL192190A0 (en) Process for the preparation of pharmaceutical salts of 3-o-(3',3'-dimethylsuccinyl) betulinic acid
WO2008009750A3 (en) Macrocyclic compounds useful as bace inhibitors
WO2007025776A3 (en) Cysteine protease inhibitors
WO2011047055A8 (en) Novel mek inhibitors, useful in the treatment of diseases
WO2008102037A8 (es) Uso de compuestos como inhibidores de la flavodoxina de helicobacter
WO2012022120A8 (zh) 二氢吡唑类化合物
PT2010538E (pt) Processo para a preparação de éster 2-[4-(4-fluoro-2- metil-1h-indol-5-iloxi)-5-metilpirrolo[2,1-f][1,2,4]- triazin-6-iloxi]-1 -metiletílico do ácido [(1r), 2s]-2- aminopropiónico

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08736697

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 12528278

Country of ref document: US

Ref document number: 2009550299

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2008736697

Country of ref document: EP